Printer Friendly
The Free Library
14,634,478 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ALTANA Posts Robust Growth in the First Six Months of 2007.


* Sales: +7 percent

* Earnings (EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become ): +22 percent

* Optimistic op·ti·mist  
n.
1. One who usually expects a favorable outcome.

2. A believer in philosophical optimism.



op
 outlook is updated

WESEL, Germany -- The specialty chemicals A Specialty chemical is a chemical produced for a specialized use. They are produced in lower volume than bulk chemicals, of which petrochemicals, made from oil feedstocks, are the most common. However, both are produced in a chemical plant.  company ALTANA AG (Pink Sheets:AAAGY) (FWB (Fixed Wireless Broadband) See fixed wireless. :ALT (character) alt - /awlt/ 1. The alt modifier key on many keyboards, including the IBM PC. On some keyboards and operating systems, (but not the IBM PC) the alt key sets bit 7 of the character generated.

See bucky bits.

2.
) (GER GER German/Germany
GER Gastroesophageal Reflux
GER Geriatrics
GER General Education Requirement
GER Great Eastern Railway (UK)
GER Gross Enrollment Ratio (education)
GER Gain Electrons Reduction
:ALT) substantially increased sales and earnings in the first six months of 2007 compared to the previous year. Sales increased by 7%, rising from EU659.0 million to EU705.7 million. Adjusted for negative exchange rate effects of 3% as well as slightly positive acquisition effects, the operating sales growth rate was 9%. The growth in sales was particularly strong in Europe (+ 10%) and Asia (+ 8%). Earnings before interest, taxes, depreciation and amortization Earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP metric that can be used to evaluate a company's profitability.
:EBITDA = Operating Revenue – Operating Expenses + Other Revenue
 (EBITDA) grew by 22% from EU103.1 million to EU125.2 million, based on double-digit earnings increases in all divisions. The EBITDA margin was 17.7%; despite additional costs due to the dual holding structure with the headquarters in Wesel and Bad Homburg Bad Hom·burg  

A city of west-central Germany at the foot of the Taunus Mountains near Frankfurt. It is a famous spa and resort. Population: 53,200.
, which was maintained until the middle of the year. Income before taxes (EBT EBT

See: Earnings Before Taxes
) reflects the extraordinary interest income of EU55.3 million from the investment of the purchase price for ALTANA Pharma realized until the distribution of the dividend in May. EBT for the first half of 2007 totaled EU138.6 million; this corresponds to an increase of EU75.9 million on the comparable prior-year figure.

All divisions are developing positively

All four divisions contributed to the substantial growth of ALTANA.

Sales in the largest division, BYK BYK Bouake Cote d'Ivoire (Ivory Coast airport code)  Additives & Instruments, climbed from EU214.1 million in the prior year to EU229.6 million; this translates into an increase of 7%. EBITDA was up from EU63.9 million to EU70.5 million, an increase of 10%.

ECKART Effect Pigments posted an increase of 8%, with sales rising from EU165.7 million to EU178.9 million. EBITDA grew significantly from EU34.1 million to EU43.9 million, and was therefore up by 29%.

Sales of ELANTAS Electrical Insulation Electrical insulation

A nonconducting material that provides electric isolation of two parts at different voltages. To accomplish this, an insulator must meet two primary requirements: it must have an electrical resistivity and a dielectric strength
 grew by 9%, up from EU167.7 million to EU182.9 million. EBITDA amounted to EU28.2 million, and was therefore up by EU5.7 million or 27% compared to the first half of 2006 (EU22.5 million).

ACTEGA Coatings & Sealants improved sales by 2%, generating EU114.3 million (prior year: EU111.5 million). EBITDA climbed from EU11.5 million to EU12.9 million, corresponding to an increase of 12%.

"In the first half-year of our new group structure as a pure specialty chemicals company we have demonstrated a very satisfying development and were able to increase sales and earnings substantially," stated Dr. Matthias Wolfgruber, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of ALTANA AG. "We have thus successfully lived up to the confidence placed in us by the capital markets and the general public after the new start of ALTANA and we are well positioned to continue our path of profitable growth into the future."

Positive outlook for the business year 2007

For the current business year, ALTANA expects an ongoing positive business environment and further increase in demand for specialty chemicals products. Raw materials prices should remain at a high level. Due to the recent currency developments we have adjusted our exchange rate expectations: the presumed U.S. Dollar rate is now 1.35 per Euro on an annual average.

Against this background and on the basis of the positive sales and earnings development of the first six months, we update our previously given outlook as follows: For 2007, we expect a mid-range single-digit growth in sales to a level of EU1.35 to EU1.39 billion and a strong double-digit growth in EBITDA to a level between EU220 and EU240 million. Effects from the intended acquisition of Wolstenholme have not been considered, as the closing of the transaction is subject to approval by the British antitrust Antitrust

The antitrust laws apply to virtually all industries and to every level of business, including manufacturing, transportation, distribution, and marketing. They prohibit a variety of practices that restrain trade.
 authorities. Income before taxes (EBT) is positively influenced by the extraordinary interest income of EU55.3 million from the investment of the proceeds from the sale of ALTANA Pharma.
[TABLE OMITTED]


A conference call for analysts will take place today, August 8, 2007, at 3:00 p.m. (local time, CEST). More information on the relevant audio webcast, this press release and the interim financial report is available at www.altana.com.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
, i.e. current estimates or expectations of future events or future results. These statements are based on beliefs of ALTANA as well as assumptions made by and information currently available to ALTANA. Forward-looking statements speak only as of the date they are made. ALTANA does not intend, and does not assume any obligation, to update forward-looking statements to reflect facts, circumstances or events that have occurred or changed after such statements have been made.

About ALTANA:

ALTANA develops and produces high-quality innovative products in the specialty chemicals business. The ALTANA Group, with headquarters in Wesel/Germany, is a genuine "global player" with 83% of its sales generated by international activities. The ALTANA Group has four divisions: BYK Additives & Instruments, ECKART Effect Pigments, ELANTAS Electrical Insulation, and ACTEGA Coatings & Sealants. All of these divisions occupy a leading position in their target markets with respect to quality, product solution expertise, innovation, and service.

ALTANA offers innovative, environmentally compatible solutions with the matching specialty products for coating manufacturers, paint and plastic processors, the printing and cosmetic industries, and the electrical and electronic industry. The product range includes additives, special coatings and adhesives, effect pigments, sealants and compounds, impregnating resins resins,
n.pl complex, insoluble, sticky substances secreted by plants. Used as astringents, antimicrobials, and antiinflammatories, and are burned as incense. Can cause oral ulcers and epidermal irritations.
 and varnishes, and testing and measuring instruments.

At present, the ALTANA Group has more than 31 production facilities and 45 service and research laboratories worldwide. Throughout the group 4,500 people work to ensure the success of ALTANA worldwide. In 2006, ALTANA achieved sales of about 1.3 billion euros. Its impressive earnings power and high growth rate make ALTANA one of the most successful and innovative chemical groups worldwide.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Financial report
Date:Aug 8, 2007
Words:953
Previous Article:adidas Group: First Half Year 2007 Results.
Next Article:Thomas Properties Group, Inc. Announces Second Quarter 2007 Results.(Financial report)
Topics:



Related Articles
Thermadyne Holdings Corporation Announces Second-Quarter and Six Months Results for Calendar Year 2007.(Financial report)(Calendar)
United-Guardian Reports Strong Six-Month Sales & Earnings.(Financial report)
Bausch & Lomb Reports Second-Quarter 2007 Financial Performance.
Clean Harbors Reports Financial Results for the Second Quarter of 2007.
The GEO Group Reports Second Quarter 2007 Results.(Financial report)
TVI Corporation Reports Second Quarter 2007 Financial Results.
Revlon Reports Second Quarter 2007 Results.
Global Partners LP Reports Second Quarter 2007 Financial Results.(Financial report)
America First Apartment Investors, Inc. Announces Results for the Second Quarter 2007.(Financial report)
Record employment levels of 1990s will soon be surpassed.(Up Front)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles